Frank X. Leonard, Chief Development Officer at NovoCure Ltd (NVCR), sold 23,806 shares at $75.94 ($1.8M) on 2022-09-01, disclosed to the SEC on 2022-09-06.
Open-market sale of $1.8M NVCR by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.88 | 240 | $18K | 1.0% |
| 2 | $75.93 | 1,200 | $91K | 4.9% |
| 3 | $75.93 | 1,200 | $91K | 4.9% |
| 4 | $75.94 | 1,047 | $80K | 4.3% |
| 5 | $75.94 | 1,047 | $80K | 4.3% |
| 6 | $76.96 | 1,750 |
| $135K |
| 7.3% |
| 7 | $77.00 | 1,914 | $147K | 8.0% |
| 8 | $77.06 | 360 | $28K | 1.5% |
| 9 | $77.92 | 2,720 | $212K | 11.5% |
| 10 | $77.92 | 2,720 | $212K | 11.5% |
| 11 | $78.09 | 2,955 | $231K | 12.5% |
| 12 | $78.09 | 2,955 | $231K | 12.5% |
| 13 | $78.14 | 438 | $34K | 1.9% |
| 14 | $78.66 | 452 | $36K | 1.9% |
| 15 | $78.68 | 1,088 | $86K | 4.6% |
| 16 | $78.68 | 1,088 | $86K | 4.6% |
| 17 | $78.96 | 48 | $4K | 0.2% |
| 18 | $79.04 | 584 | $46K | 2.5% |
| Total | $77.53 avg | 23,806 | $1.8M | 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |